What AHK-Cu is, how it compares to GHK-Cu, and how to track hair, scalp, and skin changes if you choose to use it.
At a glance
AHK-Cu is a copper-binding tripeptide made of alanine, histidine, and lysine complexed with copper. It is often discussed alongside GHK-Cu, with AHK-Cu positioned more toward hair follicle stimulation and GHK-Cu toward broader skin remodeling. The clinical evidence base is small, mostly in vitro and small cosmetic studies, and nothing here is an approved drug.
In cell and animal work, AHK-Cu has been associated with increased VEGF expression in dermal papilla cells, enlargement of hair follicles, and a longer anagen phase. The framing in self-experimenter circles is hair density and thickness rather than dramatic regrowth.
If you are combining with minoxidil, finasteride, or microneedling, that is the actual confound to plan around, not the peptide.
Most users who track honestly report modest density or thickness changes over 4–6 months, not a reversal of pattern hair loss. The peptide is unlikely to outperform established treatments like minoxidil or 5-alpha-reductase inhibitors. It may complement them.
AHK-Cu is plausible at a mechanism level and weak at a clinical-evidence level. It is most useful as a slow, low-risk addition to a tracked hair protocol, not as a primary treatment. The discipline of standardized photos and a single-variable test is what makes the experiment readable.
Peptid AI is an educational and self-tracking tool. Nothing in this post is medical advice. Doses mentioned reflect what is commonly reported in research literature — they are not recommendations. Always consult a qualified physician before starting, changing, or stopping any protocol.